Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma

Haematologica. 2015 Jul;100(7):e289-91. doi: 10.3324/haematol.2015.124164. Epub 2015 Mar 20.
No abstract available

Keywords: maintenance; panobinostat; progression-free survival; relapsed multiple myeloma.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Bortezomib / therapeutic use*
  • Clinical Trials as Topic
  • Dexamethasone / therapeutic use*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Histone Deacetylase Inhibitors / therapeutic use*
  • Humans
  • Hydroxamic Acids / therapeutic use*
  • Indoles / therapeutic use*
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology
  • Panobinostat
  • Recurrence

Substances

  • Antineoplastic Agents
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Indoles
  • Bortezomib
  • Dexamethasone
  • Panobinostat